プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
gadoversetamide
gadoversetamiid
最終更新: 2017-04-26
使用頻度: 3
品質:
optimark gadoversetamide
optimark gadoversetamiid
最終更新: 2017-04-26
使用頻度: 1
品質:
gadoversetamide is dialysable.
gadoversetamiid on dialüüsitav.
最終更新: 2017-04-26
使用頻度: 3
品質:
the active substance is gadoversetamide.
toimeaine on gadoversetamiid.
最終更新: 2017-04-26
使用頻度: 1
品質:
the active substance is gadoversetamide.
mida optimark sisaldab toimeaine on gadoversetamiid.
最終更新: 2012-04-11
使用頻度: 2
品質:
each 10 ml vial contains 3309 mg gadoversetamide.
iga 10 ml viaal sisaldab 3309 mg gadoversetamiidi.
最終更新: 2017-04-26
使用頻度: 3
品質:
each 20 ml syringe contains 6618 mg gadoversetamide.
iga 20 ml süstel sisaldab 6618 mg gadoversetamiidi.
最終更新: 2017-04-26
使用頻度: 3
品質:
gadoversetamide does not undergo protein binding in vitro.
gadoversetamiidi seostumist valkudega in vitro ei toimu.
最終更新: 2017-04-26
使用頻度: 3
品質:
dialysis can be used to remove gadoversetamide from the blood.
gadoversetamiidi eemaldamiseks verest võib kasutada dialüüsi.
最終更新: 2012-04-11
使用頻度: 2
品質:
it is unknown whether gadoversetamide is excreted in human milk.
ei ole teada, kas gadoversetamiid eritub rinnapiima.
最終更新: 2017-04-26
使用頻度: 1
品質:
optimark 500 micromol/ml solution for injection in vial gadoversetamide
optimark 500 mikromooli/ml süstelahus viaalis gadoversetamiid
最終更新: 2017-04-26
使用頻度: 1
品質:
1 ml contains 330.9 mg gadoversetamide, equivalent to 500 micromol.
1 ml sisaldab 330,9 mg gadoversetamiidi, mis on ekvivalentne 500 mikromooliga.
最終更新: 2017-04-26
使用頻度: 3
品質:
each 10 ml syringe contains 3309 mg gadoversetamide equivalent to 5 millimol.
iga 10 ml süstel sisaldab 3309 mg gadoversetamiidi, mis on ekvivalentne 5 millimooliga.
最終更新: 2017-04-26
使用頻度: 4
品質:
the pharmacokinetics of gadoversetamide conforms to a two compartment open-model.
gadoversetamiidi farmakokineetika järgib kahe ruumi avatud mudelit.
最終更新: 2017-04-26
使用頻度: 1
品質:
optimark is a solution for injection that contains the active substance gadoversetamide.
optimark on süstelahus, mis sisaldab toimeainena gadoversetamiidi.
最終更新: 2017-04-26
使用頻度: 3
品質:
distribution the pharmacokinetics of gadoversetamide conforms to a two compartment open-model.
jaotumine gadoversetamiidi farmakokineetika järgib kahe ruumi avatud mudelit.
最終更新: 2012-04-11
使用頻度: 2
品質:
the degree of excretion of gadoversetamide in breast milk has not been studied in humans.
13 gadoversetamiidi eritumisastet rinnapiima ei ole inimestel uuritud.
最終更新: 2012-04-11
使用頻度: 6
品質:
however, the administration of gadoversetamide does not cause a true decrease in serum calcium.
sellele vaatamata ei põhjusta gadoversetamiidi manustamine seerumi kaltsiumisisalduse tegelikku langust.
最終更新: 2017-04-26
使用頻度: 3
品質:
optimark 500 micromol/ ml solution for injection in a pre-filled syringe gadoversetamide
optimark 500 mikromooli/ ml süstelahus süstelis gadoversetamiid
最終更新: 2012-04-11
使用頻度: 2
品質:
in the presence of gadoversetamide, the ocp technique produces an erroneous, low value for plasma calcium.
gadoversetamiidi olemasolul annab ocp-meetod plasma kaltsiumi mõõtmisel väära (madala) tulemuse.
最終更新: 2017-04-26
使用頻度: 3
品質: